08:00 | Registration |
|
Emerging Technologies |
| |
|
Session Chair: Harald Peter, Fraunhofer |
| |
09:00 |  | Keynote Presentation Advanced Centrifugal Microfluidics for Point-of-Care Applications
Roland Zengerle, Professor, University of Freiburg, Germany
Centrifugal microfluidics enables efficient miniaturization, integration, parallelization and automation of biochemical assays especially for Point-of-Care applications. This talk will demonstrate a fully integrated sample-to-answer genotyping assay from whole blood performed within 2 hours on a small and lightweight instrument. Novel and advanced centrifugal unit operations will be discussed such as integrated pneumatic pumping and automated bead handling. Finally, challenges and solutions for the scale-up of manufacturing the polymer LabDisk will be discussed.
|
|
10:00 | Coffee and Networking in Exhibition Hall |
10:45 | Cardiac Point of Care – Current Technology and Future Directions
Paul Collinson, Consultant Chemical Pathologist, St Georges University Hospitals NHS Foundation Trust, United Kingdom
The rapid measurement of the gold standard biochemical test cardiac troponin by point of care testing (POCT) was an early innovation in patients presenting with chest pain. Strategies for more rapid diagnosis and the improved sensitivity of laboratory-based systems now create the challenge for troponin measurement by POCT. |
11:30 | Point of Care Detection of Antimicrobial Resistance with Impedance Biosensors
Till Bachmann, Reader, University of Edinburgh, United Kingdom
|
12:15 | Lunch and Networking in Exhibition Hall |
|
13:30 Poster Session | Session Sponsors |
| |
|
Session Chair: John Connor, Boston University |
| |
14:15 | Lab-on-a-chip Devices for Production and Quality Control of Dose-on-demand Radiotracers
Nicole Pamme, Professor in Analytical Chemistry, Stockholm University, Sweden
Positron Emission Tomography is a medical imaging technique that relies on the selective distribution within tissue of radiopharmaceuticals such as [18F]FDG. Microfluidic devices have been identified as attractive technology for the synthesis and processing of these pharmaceuticals due to small amounts of radioactivity handled at any one time, leading to lower shielding requirements and potentially enabling the synthesis of one dose at a time near the patient, a “dose-on-demand”. |
15:00 | Clinical Validation of a Microfluidic Point-of-care Diagnostic System for Neonatal Sepsis - ASCMicroPlat
Katherine McAllister, Research Scientist, Queens University Belfast, Ireland
Sepsis is a leading cause of infant death worldwide and patient management is challenged by diagnostic short-comings. The current gold standard for microbe-identification by blood culturing takes 2-3 days. Therefore a rapid diagnostic tool for sepsis-pathogen identification would facilitate earlier patient treatment, reducing infant morbidity and mortality. |
15:45 | Coffee and Networking in Exhibition Hall |
16:30 | "Lab-in-a-hanky" - What Comes Next after Lab-on-a-Chip
Frank Bier, Professor / Head of Division Biosystems Integration & Automation, University of Potsdam / Fraunhofer IZI-BB, Germany
|
17:15 | Novell Chip-based Extraction of miRNA
Gregory Dame, Group Leader, University of Freiburg, Germany
MicroRNAs (miRNAs) are highly conserved ~22 nt long regulatory RNAs and critical modulators of post-transcriptional gene regulation. Here we present the development of a fast on-chip (mi)RNA extraction system for point of care diagnostics, e.g. tumor analysis. |
18:00 | Drinks Reception |
